Quest Diagnostics Incorporated (DGX) — Stock Score Summary

Quest Diagnostics Incorporated (DGX) has a MoatMap StockRank of 90/100 based on Quality (60/100), Value (47/100), and Momentum (69/100) factor scores. The current signal is STRONG BUY. Quest Diagnostics is a high-quality clinical laboratory network with stable cash flows, but it does not align with our specific 18-month macro themes. It lacks the explosive pricing power of the CDMO cycle or the asymmetric upside of our commodity/energy themes.

Quest Diagnostics Incorporated provides diagnostic information services, including a broad range of routine and advanced clinical laboratory testing, medical drug testing, and anatomical pathology services. The company's competitive advantage is its extensive network of patient service centers and laboratories, a wide test menu, and strong brand reputation in diagnostic testing. Quest Diagnostics is a leading global provider of diagnostic information services, crucial for healthcare decision-making.

Key Financial Metrics

Price$204.53
Market Cap$21.7B
P/E (TTM)21.69
P/E (Forward)16.80
Price/Book2.96
Return on Equity14.5%
Return on Invested Capital11.4%
Debt/Equity82.74
Gross Margin33.3%
Operating Margin14.2%
Revenue Growth9.2%
Dividend Yield1.8%
Free Cash Flow$948M

Quest Diagnostics Incorporated operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Quest Diagnostics Incorporated’s (DGX) StockRank?
MoatMap’s StockRank for Quest Diagnostics Incorporated (DGX) is 90/100, with a Strong Buy signal. It is a composite of Quality (60), Value (47), and Momentum (69) factor ranks across MoatMap’s 19,000+ stock universe.
Does Quest Diagnostics Incorporated have an economic moat?
Quest Diagnostics Incorporated (DGX) has a Quality factor score of 60/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Quest Diagnostics Incorporated a buy, hold, or sell?
MoatMap’s current signal for Quest Diagnostics Incorporated (DGX) is Strong Buy, based on a StockRank of 90/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Quest Diagnostics Incorporated in?
Quest Diagnostics Incorporated (DGX) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksDGX deep dive reportAI ChampionsHow we score stocksSense-check another stock